
Currently out of the existing stock ratings of Uy Ear, 39 are a HOLD (23.78%), 124 are a BUY (75.61%), 1 are a SELL (0.61%).
Analyst Uy Ear, currently employed at MIZUHO, has had 36.78% of price targets met with an average potential upside of 37.72%, reached in 151 days on average.
Uy Ear has documented 310 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MBX, at 29-Jul-2026.
Analyst best performing recommendations are on QURE.
The best stock recommendation documented was for ARQT on 12/8/2023. The price target of $4 was fulfilled within 27 days with a profit of $1.84 (85.19%), with a performance score of 31.55.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Aug-2025
$40
$13.64 (51.75%)
$35
16 days ago
(05-Nov-2026)
2/4 (50%)
$13 (48.15%)
55
Buy Since 25-Feb-2020
$44
$17.64 (66.92%)
$38
1 months 2 days ago
(19-Oct-2026)
1/4 (25%)
$12.11 (37.97%)
27
Buy Since 07-Sep-2022
$40
$13.64 (51.75%)
$36
3 months 15 days ago
(06-Aug-2026)
19/25 (76%)
$13.57 (51.34%)
451
Buy Since 03-Jul-2025
$34
$7.64 (28.98%)
$32
6 months 14 days ago
(07-May-2026)
4/4 (100%)
$13.34 (64.57%)
171
Buy Since 09-Feb-2024
$35
$8.64 (32.78%)
$37
8 months 19 days ago
(02-Mar-2026)
14/41 (34.15%)
$10.24 (41.36%)
258